MSN Laboratories Private Limited

Overview

MSN Laboratories Private Limited is a leading Indian pharmaceutical company, specializing in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. They have a strong focus on innovation and deliver a wide range of therapeutics in various areas of medicine.

Core services & business areas

Therapeutic areas

Active pharmaceutical ingredients supplied

Substances MSN Laboratories Private Limited is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

MSN Laboratories Private Limited holds 268 active (275 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• OLAPARIB [ROUTE CODE WY]Active2026-03-31
• FRUQUINTINIB [ROUTE CODE FQZ]Active2026-03-31
• FRUQUINTINIBActive2026-03-30
• PIRTOBRUTINIB [ROUTE CODE PKZ]Active2026-03-30
• SELUMETINIB SULFATEActive2026-03-29
• BINIMETINIB [ROUTE CODE BTK]Active2026-03-29
• DAPAGLIFLOZIN PROPANEDIOL (MONOHYDRATE)Active2026-03-29
• RUXOLITINIB PHOSPHATE [ROUTE CODE: RKP]Active2026-03-29
• DEXLANSOPRAZOLE (SESQUIHYDRATE)Active2026-03-28
• DAPAGLIFLOZIN AMORPHOUSActive2026-03-26
• BINIMETINIB [ROUTE CODE BTQ]Active2026-03-26
• DEUCRAVACITINIBActive2026-03-24
• PIRTOBRUTINIBActive2026-03-24
• METHOTREXATE USPActive2026-01-21
• NIRAPARIB TOSYLATEActive2025-12-27

Showing 15 of 275 Drug Master Files.

FDA compliance signals